A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HSCT / hematopoietic stem cell

[Related PubMed/MEDLINE]
Total Number of Papers: 45
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HSCT  (>> Co-occurring Abbreviation)
Long Form:   hematopoietic stem cell
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. CMV, SOT
2019 Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. PTLD
2019 PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories. PTLD, SOT
2019 Severely bothersome fatigue in children and adolescents with cancer and hematopoietic stem cell transplant recipients. CI, OR, SSPedi
2019 Taste changes in children with cancer and hematopoietic stem cell transplant recipients. ALL, CI, OR, PeNAT, SSPedi
2019 The use of comprehensive geriatric assessment in older patients before allologeneic hematopoietic stem cell transplantation: A cross-sectional study. CGA, DRI, GDS, HCT-CI, HCT-SCI, IADL
2018 Burden of severe RSV disease among immunocompromised children and adults: a 10year retrospective study. LRTI, RSV
2018 Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results. CLASS, CRF
2017 A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood. BMT, GVHD, HRQoL
10  2017 Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. ---
11  2016 Current therapies for Morquio A syndrome and their clinical outcomes. ERT
12  2016 Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease. KD
13  2015 Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation. RSV
14  2014 Impact of Enzyme Replacement Therapy and Hematopoietic Stem Cell Therapy on Growth in Patients with Hunter Syndrome. ERT
15  2014 Methods of detection of immune reconstitution and T regulatory cells by flow cytometry. ---
16  2014 Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients. AUC, CsA, ITS, LSS
17  2014 Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. AdV, CCS, CMV, EBV, HHV, SOT
18  2013 Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution. GVHD
19  2013 Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. GVHD, OM
20  2013 Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. CTL, EBV, IFN-gamma, PTLD, SOT, TAC
21  2013 Role of donor and recipient sex in platelet transfusion. PLT, PPR
22  2013 The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. CMV, GRMs, pGRM, sGRM
23  2012 Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. BBB, CNS, ERT, GAGs, IDS, IVA, MPS II
24  2011 Acute graft versus host disease in hematopoietic stem cell alotransplant recipients. GVHD
25  2011 Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. HIV-1
26  2011 Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. BSI-18, DT, MFSI
27  2011 Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. C6S, ERT, GAGs, KS, MPS IVA
28  2008 Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. ---
29  2008 Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab. CNS, EBV, PTLD
30  2007 Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. MRT
31  2007 Rehabilitation of chronic graft versus host disease in children. A clinical series. cGVHD
32  2007 Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81. BSI, CDI, FUO, ONC
33  2006 A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients. BKV, HC, RD, URD
34  2006 Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. CMV, MVA, NAb, SOT
35  2006 EBMT activity survey 2004 and changes in disease indication over the past 15 years. ---
36  2006 [The impact of stem cell therapy in hematology and oncology]. ---
37  2005 Severe combined immunodeficiency. A model disease for molecular immunology and therapy. SCIDs
38  2005 The role of immune ablation and stem cell transplantation in severe SLE. ---
39  2004 Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey. EBMT
40  2004 Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation. GVHD, TCR
41  2004 Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. AdV
42  2003 G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. G-CSF, GVHD
43  2002 Immunogenetic selection of donors for haematopoietic stem cell transplantation: an approach. ---
44  2001 Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. alpha1-MG, beta-NAG, THP
45  2000 Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease. AML, CsA, EBV, GVHD, HLA, PTLD